Effect of care transfer model led by the hospital clinical pharmacist on reduction of hospital readmissions in the elderly.

IF 1.5 4区 医学 Q4 CHEMISTRY, MEDICINAL Pharmazie Pub Date : 2024-05-15 DOI:10.1691/ph.2024.3666
I Marinović, V Baćićrca, S Marušić, I Grgurević, M Brkić, N Jambrek, J Mesarić, I Samardžić
{"title":"Effect of care transfer model led by the hospital clinical pharmacist on reduction of hospital readmissions in the elderly.","authors":"I Marinović, V Baćićrca, S Marušić, I Grgurević, M Brkić, N Jambrek, J Mesarić, I Samardžić","doi":"10.1691/ph.2024.3666","DOIUrl":null,"url":null,"abstract":"<p><p>Transfer of care is a critical point for patient safety and requires an optimal care transfer model in order to ensure safe pharmacotherapy transfer. Polypharmacy among elderly is associated with adverse health consequences such as hospital readmissions. Hospital readmissions represent priorities in health care research and are one of the measures for assessing patient safety. Medication-related problems among elderly are associated with polypharmacy. The aim of the study was to show the impact of a developed model of care transfer led by a hospital clinical pharmacist on the number of hospital readmissions in the 12-months period in the elderly. A randomized controlled study of patients aged 65 or more was conducted at Dubrava University Hospital, Community Health Centre Zagreb - East and community pharmacies in the City of Zagreb and Zagreb County, Croatia. An intervention group received specially designed care transfer led by the hospital clinical pharmacist. Model included high-intensity pharmacotherapy interventions delivered at admission, during hospital stay and discharge, transition to primary care and post-discharge and cooperation between all healthcare professionals. In all, 182 patients in the intervention and 171 in the control group were analysed. The total number of hospital readmissions and emergency readmissions, within one year from the hospital discharge, was lower in the intervention group than in the control group (41.7% <i>vs.</i> 58.3%, p=0.005; 40.8% <i>vs.</i> 59.2%, p=0.008). The model of the health care transfer applied in this research thus significantly reduced hospital readmissions in the 1-year period in elderly patients. Therefore, the hospital clinical pharmacists should design and coordinate the transfer between hospital and primary care.</p>","PeriodicalId":20145,"journal":{"name":"Pharmazie","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmazie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1691/ph.2024.3666","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Transfer of care is a critical point for patient safety and requires an optimal care transfer model in order to ensure safe pharmacotherapy transfer. Polypharmacy among elderly is associated with adverse health consequences such as hospital readmissions. Hospital readmissions represent priorities in health care research and are one of the measures for assessing patient safety. Medication-related problems among elderly are associated with polypharmacy. The aim of the study was to show the impact of a developed model of care transfer led by a hospital clinical pharmacist on the number of hospital readmissions in the 12-months period in the elderly. A randomized controlled study of patients aged 65 or more was conducted at Dubrava University Hospital, Community Health Centre Zagreb - East and community pharmacies in the City of Zagreb and Zagreb County, Croatia. An intervention group received specially designed care transfer led by the hospital clinical pharmacist. Model included high-intensity pharmacotherapy interventions delivered at admission, during hospital stay and discharge, transition to primary care and post-discharge and cooperation between all healthcare professionals. In all, 182 patients in the intervention and 171 in the control group were analysed. The total number of hospital readmissions and emergency readmissions, within one year from the hospital discharge, was lower in the intervention group than in the control group (41.7% vs. 58.3%, p=0.005; 40.8% vs. 59.2%, p=0.008). The model of the health care transfer applied in this research thus significantly reduced hospital readmissions in the 1-year period in elderly patients. Therefore, the hospital clinical pharmacists should design and coordinate the transfer between hospital and primary care.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
由医院临床药剂师主导的护理转移模式对减少老年人再住院率的影响。
护理转移是患者安全的关键点,需要一个最佳的护理转移模式,以确保安全的药物治疗转移。老年人使用多种药物与再入院等不良健康后果有关。再入院率是医疗保健研究的重点,也是评估患者安全的措施之一。老年人的用药相关问题与多重用药有关。该研究旨在展示由医院临床药剂师主导的护理转移模式对老年人 12 个月内再入院次数的影响。这项随机对照研究在克罗地亚杜布拉瓦大学医院、萨格勒布东部社区卫生中心以及萨格勒布市和萨格勒布县的社区药房进行,对象是 65 岁或以上的患者。干预组接受由医院临床药剂师领导的特别设计的护理转移。该模式包括在入院时、住院期间和出院时、转入初级保健时和出院后提供高强度的药物治疗干预,以及所有医护人员之间的合作。共对干预组的 182 名患者和对照组的 171 名患者进行了分析。干预组在出院后一年内再入院和急诊再入院的总人数低于对照组(41.7% 对 58.3%,P=0.005;40.8% 对 59.2%,P=0.008)。因此,本研究中应用的医护转移模式大大降低了老年患者一年内的再住院率。因此,医院临床药剂师应设计并协调医院与基层医疗机构之间的转诊。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pharmazie
Pharmazie 医学-化学综合
CiteScore
3.10
自引率
0.00%
发文量
56
审稿时长
1.2 months
期刊介绍: The journal DiePharmazie publishs reviews, experimental studies, letters to the editor, as well as book reviews. The following fields of pharmacy are covered: Pharmaceutical and medicinal chemistry; Pharmaceutical analysis and drug control; Pharmaceutical technolgy; Biopharmacy (biopharmaceutics, pharmacokinetics, biotransformation); Experimental and clinical pharmacology; Pharmaceutical biology (pharmacognosy); Clinical pharmacy; History of pharmacy.
期刊最新文献
Analysis and evaluation of factors contributing to the occurrence of immune-related adverse events with immune checkpoint inhibitors. Effect of genetic factors on the interindividual variability of warfarin dosage requirements in Japanese patients after adjusting for renal function. Investigations on 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,2-a]pyridazin-1-amines and related compounds: synthesis, chemical behaviour, structure elucidation and iNOS inhibitory activity. Management of apixaban anticoagulation in a patient requiring therapeutic plasma exchange: a case report and a literature review. Metabolism of baicalin by different microbiota determined by MimiCol.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1